Windlas Biotech (WINDLAS) Stock Overview

Windlas Biotech Limited, a contract development and manufacturing organization (CDMO), manufactures and trades in pharmaceutical products in India and internationally. The company offers CDMO services, including product discovery, product development, licensing, and commercial manufacturing of generic products. It manufactures nutraceutical supplement products. In addition, the company manufactures tablets, capsules, pouches, sachets, and liquid bottles; and generic products portfolio comprises fixed dosage combinations, fixed dosage plus modified release combinations, customized generics, and chewable or dispersible. The company was incorporated in 2001 and is based in Gurugram, India.